India's Natco Pharma slips after FDA 'observation' on facility

Natco Pharma

16/06/2025 05:46

** Shares of Natco Pharma NATP.NS down nearly 2% to 897 rupees

** Drugmaker says U.S. FDA inspected its Hyderabad facility and noted "one observation"

** Co did not elaborate on the observation, but said it was "procedural" and that it was confident it could address it comprehensively

** Stock, on avg, rated "hold" with median PT 935.50 rupees - data compiled by LSEG

** YTD stock down 36%

 (Reporting by Hritam Mukherjee in Bengaluru)

 ((Hritam.Mukherjee@thomsonreuters.com;))